3-(2-(Methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride

Catalog No. :
ACCBWG442
CAS No. :
2034155-48-9
Molecular Formula :
C12H15ClN2O2S2
Molecular Weight :
318.85

IUPAC Name:3-(2-(methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride

3-(2-(Methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(2-(Methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride
IUPAC Name3-(2-(methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride
Molecular FormulaC12H15ClN2O2S2
Molecular Weight318.85
SMILESN=C1SC2=CC(OCCO3)=C3C=C2N1CCSC.[H]Cl
InChI KeyWPFQFHZJIBTYET-UHFFFAOYSA-N
Synonym3-(2-(Methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2',3':4,5]benzo[1,2-d]thiazol-2(3H)-imine hyd;3-(2-(methylthio)ethyl)-6,7-dihydro-[1,4]dioxino[2,3:4,5]benzo[1,2-d]thiazol-2(3H)-imine hydrochloride
CAS No.2034155-48-9

Synthetic Route by SureRoute

1. ACCBWG442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXWIA415 route compound structure diagram
    ACXWIA41554187-93-8 In Stock
  2. Plus
  3. ACEIUW289 route compound structure diagram
    ACEIUW289313223-82-4 In Stock
  4. Then
  5. ACCBWG442 route product structure diagram
    ACCBWG4422034155-48-9
Inquiry

2. ACCBWG442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUDVW867 route compound structure diagram
    ACUDVW867542-81-4 In Stock
  2. Plus
  3. ACEIUW289 route compound structure diagram
    ACEIUW289313223-82-4 In Stock
  4. Then
  5. ACCBWG442 route product structure diagram
    ACCBWG4422034155-48-9
Inquiry

Comments (0)